Skip to main content
Equibles

Aida Habtezion, M.D.

Board Member

Azora Therapeutics, Inc. (DE) (AZR)

Equibles does not estimate personal net worth.

Get an email with a short summary when Azora Therapeutics, Inc. (DE) publishes a filing, an earnings call transcript or a press release.

Get AZR alerts

About Aida Habtezion, M.D.

Aida Habtezion, M.D. is recorded as Board Member at Azora Therapeutics, Inc. (DE) (AZR) since November 3, 2026. Azora Therapeutics, Inc. (DE) reported in an 8-K filed November 9, 2026 that Aida Habtezion, M.D. was appointed Class I director, effective November 3, 2026. Azora Therapeutics, Inc. (DE) is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Azora Therapeutics, Inc. (DE) includes Matthew Davidson (CEO and Chairman), Matthew Davidson, Ph.D. (CEO), William B. Stilley (CEO) and 7 others.

“On November 3, 2026, each of Aida Habtezion, M.D., Paul Hastings and Thomas Soloway were appointed to the Board of Directors (the “Board”) of Azora Therapeutics, Inc. (formerly known as Adial Pharmaceuticals, Inc.) (the “Company”).”
Azora Therapeutics, Inc. (DE) Form 8-K, filed November 9, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Azora Therapeutics, Inc. (DE)

Recent activity